S. Bayat (Grenobe, France), W. Stringer (Long Beach, United States of America)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Pulmonary function after COVID-19 infection and the impact of disease severity.
M. Thomas (Birmingham, United Kingdom), H. Won (Seoul, Republic of Korea), O. Price (Leeds, United Kingdom), W. Song (Ulsan, Republic of Korea), J. Hull (London, United Kingdom)
|    |
Neural respiratory drive in survivors of severe COVID-19 pneumonitis
C. Jolley (London, United Kingdom), R. D'Cruz (London, United Kingdom), S. Mathew (London, United Kingdom), A. Byrne (London, United Kingdom), M. Choudhury (London, United Kingdom), T. Fleming (London, United Kingdom), G. Rafferty (London, United Kingdom), J. Moxham (London, United Kingdom), P. Murphy (London, United Kingdom), N. Hart (London, United Kingdom), S. Birring (London, United Kingdom), J. Periselneris (London, United Kingdom), F. Perrin (London, United Kingdom), A. Patel (London, United Kingdom), I. Patel (London, United Kingdom), M. Waller (London, United Kingdom)
| |
The role of 6MWT in Covid-19 follow up
M. Ferioli (Bologna, Italy), I. Prediletto (Bologna, Italy), S. Bensai (Bologna, Italy), S. Betti (Bologna, Italy), F. Daniele (Bologna, Italy), V. Di Scioscio (Bologna, Italy), C. Modolon (Bologna, Italy), M. Rimondi (Bologna, Italy), S. Nava (Bologna, Italy), L. Fasano (Bologna, Italy)
| |
Half of COVID-19 ICU-treated patients have impaired lung function four months after discharge
E. Ekbom (Uppsala, Sweden), R. Frithiof (Uppsala, Sweden), Ö. Emilsson (Uppsala, Sweden), I. Larsson (Uppsala, Sweden), M. Lipscey (Uppsala, Sweden), S. Rubertsson (Uppsala, Sweden), E. Wallin (Uppsala, Sweden), C. Janson (Uppsala, Sweden), M. Hultström (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
The impact of COVID-19 on children with chronic suppurative lung disease
T. Tolufase (London, United Kingdom), M. Osinibi (London, United Kingdom), E. Kavaliunaite (London, United Kingdom), M. Thorogood (London, United Kingdom), A. Gupta (London, United Kingdom), S. Pierce (London, United Kingdom), C. Bossley (London, United Kingdom)
| |
Pulmonary function 45 and 180 days after COVID-19 hospitalization: does time, in fact, heal all wounds?
E. Viana Mancuzo (Belo Horizonte (MG), Brazil), C. Marinho (Belo Horizonte (MG), Brazil), J. Das Graças Ferreira Oliveira (Belo Horizonte (MG), Brazil), A. Priscila Batista (Ouro Preto (MG), Brazil), L. Gustavo Guimaraes Sacramento (Belo Horizonte (MG), Brazil), A. Lucca Torres Brandão (Belo Horizonte (MG), Brazil), S. Carlos Rodrigues Da Silva (Belo Horizonte (MG), Brazil), P. Chaves Ferreira (Belo Horizonte (MG), Brazil), A. Sophia Mitre Leite (Belo Horizonte (MG), Brazil), J. Reinaldo Correia Roveda (Belo Horizonte (MG), Brazil), B. Horta Andrade (Belo Horizonte (MG), Brazil), T. Aline Prata (Belo Horizonte (MG), Brazil), D. Cruz Bretas (Belo Horizonte (MG), Brazil), A. Luísa Ribeiro Reis (Belo Horizonte (MG), Brazil), A. Maria De Carvalho Oliveira (Belo Horizonte (MG), Brazil), G. Vinícius Do Carmo Eugênio (Belo Horizonte (MG), Brazil), H. Romão Moreira (Belo Horizonte (MG), Brazil), J. Elias Morato (Belo Horizonte (MG), Brazil), P. Ntônio Oliveira Aquino Gusmão (Belo Horizonte (MG), Brazil), G. Luiz Lins Machado Coelho (Ouro Preto (MG), Brazil), A. Santos Leite (Belo Horizonte (MG), Brazil), V. Maria Augusto (Belo Horizonte (MG), Brazil)
| |
Which severe COVID-19 patients may benefit the most from pulmonary rehabilitation?
M. Marillier (Grenoble, France), Y. Al Chikhanie (Grenoble, France), D. Veale (Dieulefit, France), F. Hérengt (Dieulefit, France), S. Vergès (Grenoble, France)
| |
Association between symptoms and objective physiological outcomes in severe COVID-19 pneumonia survivors
P. Zamani (London, United Kingdom), S. Mehrotra (London, United Kingdom), R. D'Cruz (London, United Kingdom), S. Mathew (London, United Kingdom), A. Byrne (London, United Kingdom), M. Choudhury (London, United Kingdom), T. Fleming (London, United Kingdom), S. Norton (London, United Kingdom), S. Birring (London, United Kingdom), A. Patel (London, United Kingdom), I. Patel (London, United Kingdom), F. Perrin (London, United Kingdom), M. Waller (London, United Kingdom), C. Jolley (London, United Kingdom)
| |
Diaphragm neurostimulation on every breath preserves alveolar homogeneity.
E. Rohrs (Burnaby, Canada), T. Bassi (Burnaby, Canada), K. Fernandez (Burnaby, Canada), M. Ornowska (Burnaby, Canada), M. Nicholas (Burnaby, Canada), J. Wittmann (Burnaby, Canada), S. Reynolds (Burnaby, Canada)
| |
Late Breaking Abstract - Lung function before and after COVID-19 infection in young adults
I. Mogensen (Stockholm, Sweden), J. Hallberg (Stockholm, Sweden), S. Björkander (Stockholm, Sweden), Q. Pan-Hammarström (Stockholm, Sweden), L. Palmberg (Stockholm, Sweden), C. Janson (Uppsala, Sweden), A. Bergström (Stockholm, Sweden), E. Melén (Stockholm, Sweden), I. Kull (Stockholm, Sweden)
| |
Discussion
| |